TrialInternational journal of clinical oncology2013

A phase II study to evaluate the efficacy and toxicity of oxaliplatin in combination with gemcitabine in carcinoma of unknown primary.

Heather Carlson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.